Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq
Other stock markets
 01:30:00 12/06/2024 am IST 		5-day change 1st Jan Change
0.2666 USD +2.97% Intraday chart for GlycoMimetics, Inc. -9.29% -88.70%
04/06 Transcript : GlycoMimetics, Inc. - Special Call
04/06 GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GLYCOMIMETICS, INC. Stock GlycoMimetics, Inc.
 1.67Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.36TCr -
ARGENX SE Stock argenx SE
 2.24TCr -
GENMAB A/S Stock Genmab A/S
 1.78TCr
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Charts GlycoMimetics, Inc.
  5. Sector Chart